… indication performed in mice, we classified the drug as developed using mice for that …
The role of the NMDA receptors and L-arginine–nitric oxide–cyclic guanosine monophosphate …

… Results: PnPP-19 induced central antinociception in mice in … system and induce antinociception
mediated by activation of … Central antinociception induced by ketamine is mediated by …

… pathway in melatonin-induced peripheral antinociception. We used the paw compression
method to evaluate the nociceptive threshold of male Swiss mice … effect through the activation …

… determine the antinociceptive effect in non-diabetic rats and … the antinociceptive and
antiallodynic effect induced by EPO. … -κB, activation of NO-GMPc-KATP pathway and activation of 5…

… the paw compression test in mice. Cannabidiol was administered … , did not cause alteration
in CBD-induced antinociception. … is mediated by the activation of cannabinoid and opioid …

… cyclase (sGC) and levels of cyclic guanosine monophosphate (cGMP), data obtained by …
DA-mediated peripheral antinociception is the result of the concomitant activation of D2 family …

… , the method of removing rat paws subjected to compression … ), which block channels activated
by low and high conductance … , the peripheral antinociceptive action induced by tramadol …

… mice (males, ± 45 days) in the paw edema test induced … antinociceptive action of EHPa;
In the inflammatory phase, L-NAME was able to further increase the peripheral antinociceptive …

… antinociceptive effect profile, with 100 μg sufficient for the maximum effect. We did not see
the participation of the opioidergic system in antinociception … in the antinociceptive effect of L-…

… their mechanisms of action the activation of receptors coupled to … For this, Wistar rats, weighing
180 g, were used for sciatic … in analgesic processes both in induction and in consolidated …